Practical guidance on pharmaceutical CSV, QA, data integrity, and regulatory compliance - written and reviewed by Mohammad Awawdeh.
Subscribe via RSSBrowse by topic
Start with the service that matches your objective, then use its connected guides to plan the work.
A practical Validation 4.0 roadmap connecting risk-based validation, digital workflows, data integrity, automation and human quality oversight.
Read guide & explore PHARPRO DVS →How pharmaceutical companies can implement digital validation workflows for URS, risk assessment, IQ/OQ/PQ, RTM, review and electronic approval.
Read guide & explore PHARPRO DVS →Explore PHARPRO DVS for connected URS, risk assessment, IQ/OQ/PQ, RTM, audit trails, controlled review and AI-assisted validation drafting.
Read guide & explore PHARPRO DVS →A governance guide for using AI in pharmaceutical validation while maintaining human approval, traceability, data integrity and risk-based oversight.
Read guide & explore PHARPRO DVS →Explore practical AI use cases in pharma across validation, quality, manufacturing and knowledge work, with governance and human oversight controls.
Read guide & explore PHARPRO DVS →PHARPRO thermal mapping services for pharmaceutical warehouses, cold rooms, freezers, stability chambers and temperature-controlled areas across MENA.
Read the service guide →PHARPRO turnkey validation projects covering VMP, CQV, CSV, utilities, equipment, process, cleaning, protocols, execution and approved handover.
Read the service guide →PHARPRO environmental monitoring testing and program support for pharmaceutical cleanrooms: viable and non-viable monitoring, trending and investigation.
Read the service guide →How to design a defensible cold-room study: risk-based logger positions, empty and loaded testing, door-opening challenges, alarms and final reporting.
Read article →A lifecycle guide to URS, DQ, FAT/SAT, IQ/OQ/PQ, deviations, release, continued verification and risk-based requalification.
Read article →Connect cleanroom use and contamination risk to HEPA integrity, airflow, pressure, recovery, classification and performance qualification.
Read article →Practical controls for governance, ALCOA+, hybrid records, audit trails, access, review, investigations and sustainable remediation.
Read article →Two-day comprehensive GMP training: 12 modules covering regulatory frameworks, QMS, data integrity (ALCOA+), equipment qualification, CAPA, change control & inspection readiness. Certificate of Completion. Online & in-person. Last cohort before Q4 inspection season. Limited to 30 seats.
Read article & register →PHARPRO CSV Training rescheduled from 5–6 August to 27 & 28 October 2026. Two-day intensive: GAMP 5 Second Edition risk model, IQ/OQ/PQ protocol writing, data integrity (ALCOA+), FDA 21 CFR Part 11, EU GMP Annex 11 & a full case study. Certificate of Completion. Online & in-person. Limited to 20 seats.
Read article & register →PHARPRO announces a new partnership covering end-to-end drug registration across Jordan (JFDA), Syria, Lebanon, and GCC markets — dossier preparation, regulatory submissions, and post-approval maintenance. Free initial consultation available.
Read announcement & enquire →PHARPRO's new pharma marketing partnership delivers brand positioning, HCP outreach, KOL engagement, and compliant promotional materials for pharmaceutical companies entering or growing in the Jordanian market. Enquire for a proposal.
Read announcement & enquire →How pharma teams can move from disconnected Word and Excel CSV work to controlled digital validation software for URS, risk assessment, IQ/OQ/PQ, RTM, electronic approvals and audit trails — aligned with GAMP 5, FDA 21 CFR Part 11 and EU GMP Annex 11.
Read the digitalization guide →Model software cost, internal effort, rework and review time using your own baseline. Includes a transparent framework for pilot measurement instead of unsupported savings claims.
Build the ROI case →What GSDP is, what JFDA requires for pharmaceutical storage and distribution facilities in Jordan, and how PHARPRO helps companies achieve and maintain compliance — including temperature monitoring, GDP documentation, and inspection readiness.
Read article →A risk-based migration plan for moving validation records, requirements traceability, review and approvals out of disconnected office files.
Read the migration guide →PHARPRO's structured gap assessment covers FDA 21 CFR Part 11, EU GMP Annex 11, and GAMP 5. Deliverable: written gap report with risk-prioritised remediation roadmap. Free initial consultation — no commitment.
Request free assessment →PHARPRO DVS is AI validation lifecycle software with 30 document builders from URS to VSR - compared to manual Word/Excel approaches, reviewed for FDA 21 CFR Part 11 and EU GMP Annex 11 compliance.
Read article →50 questions your QA team should answer before any FDA, EU GMP, or national authority inspection. Print-ready and free.
Get the checklist →DVS-PQR workflow launched, validation work completed, thermal mapping training expanded to Pakistan, and PHARPRO project activity summarized for June 2026.
Read the full update →What ISPE GAMP 5 Second Edition means for your validation programme - new three-category risk model, critical thinking principles, cloud system guidance, and what to update in your existing documentation.
Read article →A practical checklist covering every major area EU GMP inspectors assess - supplier qualification, validation documentation, audit trails, access controls, change control, and periodic review.
Read article →How to build an effective CAPA system - root cause analysis, corrective actions, effectiveness checks, and what FDA and EU GMP inspectors expect to see in your CAPA records.
Read article →Received an FDA Warning Letter? How to structure your response, address observations correctly, avoid common mistakes, and restore regulatory standing step by step.
Read article →A practical guide to qualifying pharma suppliers - the risk-based approach, audit checklist, quality agreements, and ongoing monitoring requirements under EU GMP Chapter 5 and FDA 21 CFR.
Read article →How to validate SaaS and cloud-hosted GxP systems - GAMP 5 category classification, vendor qualification, data integrity controls, and change management for vendor-initiated updates.
Read article →How to prepare your pharmaceutical site for an FDA, EU GMP, or national authority inspection - documentation review, data integrity checks, staff briefing, and mock audits.
Read article →What a VMP must contain, who approves it, how it links to your validation programme - and the common gaps regulators find in Validation Master Plans during EU GMP and FDA inspections.
Read article →System-level and functional risk assessment for computerised systems - GAMP 5 categories, risk-based testing, and how to document your risk rationale in an audit-ready format.
Read article →How to build and maintain a training matrix, what records regulators require, and the most common GMP training findings that lead to inspection observations - and how to avoid them.
Read article →Electronic records, audit trails, electronic signatures, and access controls - exactly what 21 CFR Part 11 requires, and the seven compliance gaps that most commonly generate FDA warning letters.
Read article →Complete knowledge base
Use these connected topic paths to move from a regulatory question to an implementation-ready plan.
Mohammad answers practical compliance questions - no sales pitch, just straight answers.
Get a Free Assessment